GSK3B and Alzheimer disease: Shutdown of the transgene in Tet/GSK-3β mice with signs of AD pathology leads to normal GSK-3 activity, normal levels of phosphorylated tau, reduced neuronal death and reactive gliosis, and improvement of cognitive deficits [75].